Abera Bioscience AB announced that it will issue 1,114,363 shares at a price of SEK 15.30 per share for gross proceeds of SEK 17,000,000 in a round of funding on June 9, 2021. The transaction will include participation from a group of existing and external qualified investors. The transaction has been approved by the board of directors of the company at its Annual General Meeting.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.4 SEK | +5.47% | +12.50% | +4.65% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.65% | 7.75M | |
+44.48% | 55.07B | |
+43.62% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- ABERA Stock
- News Abera Bioscience AB
- Abera Bioscience AB announced that it expects to receive SEK 17.049754 million in funding